PQ 109
109. Deputy David Cullinane asked the Minister for Health the reason none of the four products currently recommended for use in the medical cannabis access programme meet the criteria of less than 2% THC for use in the treatment of resistant epilepsy established in the clinical guidance on cannabis for medical use of his Department; his plans to address same; and if he will make a statement on the matter. [22375/21]
Introduced
29 April 2021
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
29 April 2021
Summary
109. Deputy David Cullinane asked the Minister for Health the reason none of the four products currently recommended for use in the medical cannabis access programme meet the criteria of less than 2% THC for use in the treatment of resistant epilepsy established in the clinical guidance on cannabis for medical use of his Department; his plans to address same; and if he will make a statement on the matter. [22375/21]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Cannabis for Medicinal Use
Cannabis for Medicinal Use
xml · EN · 29 April 2021
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2021-04-29/109/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2021-04-29/pq_109